PARLIAMENTARY WRITTEN QUESTION
Continuing Care (9 June 2014)

To ask the Secretary of State for Health, what steps his Department is taking to ensure that the Clinical Priorities Advisory Group takes account of evidence from (a) patients, (b) clinicians and (c) patient groups when making decisions on the availability of treatments for progressive conditions.

Asked by:
Mr Clive Betts (Labour)

NHS England has advised that the Clinical Priorities Advisory Group (CPAG) is an advisory group and not a decision making body. It considers policy and makes recommendations to the Directly Commissioned Services Committee who make the final decisions on NHS England's commissioning position.

The Group's membership includes four Patient and Public Voice members and senior clinicians from NHS England. The policies that are presented to CPAG for consideration are developed by Clinical Reference Groups (CRGs) who are made up of patients, clinicians, and key stakeholders including patient groups. These members are involved in the development of policies.

Prior to submission of any documents to CPAG, a two week stakeholder testing phase is undertaken where registered CRG stakeholders including clinicians, patients, and patient groups, as well as industry, have an opportunity to make comments. These are considered as well as the evidence base for the policy by CPAG.

Answered by:
Jane Ellison (Conservative)
16 June 2014